Pillstats
Rx only · Tablet · Oral

Ethambutol Hydrochloride

Ethambutol Hydrochloride

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4110
US makers3 labelers
Packages5
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.125$0.249$0.374$0.499Dec 2025Apr 2026Jul 2026
$0.420
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
3
Active US suppliers
80%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.1K2.2K3.3K4.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.2K
Rx · 2026 Q1
241K
Units dispensed
-12%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
REMEDYREPACK INC.repackager2SUPPLYING
American Health Packagingunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Feb 22, 2013
    RECALLRecall (Class III): Ethambutol Hydrochloride Tablets USP, 400 mg, 100-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.…

    Failed Impurities/Degradation Specifications: This product is being recalled due to an out of specification result for an impurity. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide